Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2015 (2015), Article ID 970750, 8 pages
http://dx.doi.org/10.1155/2015/970750
Research Article

Myocardial Infarction and Stroke Risk in Young Healthy Men Treated with Injectable Testosterone

1Low T Institute, Dallas, TX 76092, USA
2University of Texas, Houston, TX 77030, USA
3Baylor College of Medicine, Houston, TX 77030, USA
4Michael DeBakey VAMC, Houston, TX 77030, USA
5Opal Medical Clinic, Houston, TX 77098, USA

Received 28 November 2014; Accepted 7 January 2015

Academic Editor: Manuel Estrada

Copyright © 2015 Robert S. Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. D. Finkle, S. Greenland, G. K. Ridgeway et al., “Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men,” PLoS ONE, vol. 9, no. 1, Article ID e85805, 2014. View at Publisher · View at Google Scholar
  2. R. Vigen, C. I. O'Donnell, A. E. Baron et al., “Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels,” Journal of the American Medical Association, vol. 310, no. 17, pp. 1829–1836, 2013. View at Publisher · View at Google Scholar
  3. L. T. Center, July 2014, https://lowtcenter.com/about.
  4. S. Bhasin, G. R. Cunningham, F. J. Hayes et al., “Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2536–2559, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Force AHT, “American association of clinical endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update,” Endocrine Practice, vol. 8, no. 6, pp. 439–456, 2002. View at Publisher · View at Google Scholar
  6. AdvancedMD, 2014, http://www.advancedmd.com/.
  7. J. Fang, M. H. Alderman, N. L. Keenan, and C. Ayala, “Acute myocardial infarction hospitalization in the United States, 1979 to 2005,” The American Journal of Medicine, vol. 123, no. 3, pp. 259–266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. R. T. Greenlee, A. L. Naleway, and H. Vidaillet, “Incidence of myocardial infarction in a general population: the Marshfield Epidemiologic Study Area,” Wisconsin Medical Journal, vol. 101, no. 7, pp. 46–52, 2002. View at Google Scholar · View at Scopus
  9. H. Kilburn Jr., L. Schoen, and T. Wang, “Acute myocardial infarction in New York State: 1996–2008,” Journal of Community Health, vol. 37, no. 2, pp. 473–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Yamaki, K. Nakazato, M. Kijima, Y. Maruyama, and Y. Takeishi, “Impact of the Great East Japan Earthquake on acute myocardial infarction in Fukushima prefecture,” Disaster Medicine and Public Health Preparedness, vol. 8, no. 3, pp. 212–219, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. R. L. Sacco, D. E. Kargman, Q. Gu, and M. C. Zamanillo, “Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: the Northern Manhattan stroke study,” Stroke, vol. 26, no. 1, pp. 14–20, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Haider, M. Zitzmann, G. Doros, H. Isbarn, P. Hammerer, and A. Yassin, “Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries,” The Journal of Urology, vol. 193, no. 1, pp. 80–86, 2015. View at Publisher · View at Google Scholar
  13. E. Barrett-Connor and K.-T. Khaw, “Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study,” Circulation, vol. 78, no. 3, pp. 539–545, 1988. View at Publisher · View at Google Scholar · View at Scopus
  14. A. E. Hak, J. C. M. Witteman, F. H. de Jong, M. I. Geerlings, A. Hofman, and H. A. P. Pols, “Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study,” The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 8, pp. 3632–3639, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. G. B. Phillips, B. H. Pinkernell, and T. Y. Jing, “The association of hyperestrogenemia with coronary thrombosis in men,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 11, pp. 1383–1387, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. K.-T. Khaw and E. Barrett-Connor, “Blood pressure and endogenous testosterone in men: an inverse relationship,” Journal of Hypertension, vol. 6, no. 4, pp. 329–332, 1988. View at Google Scholar · View at Scopus
  17. F. Dockery, C. J. Bulpitt, S. Agarwal, M. Donaldson, and C. Rajkumar, “Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia,” Clinical Science, vol. 104, no. 2, pp. 195–201, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. Group TAS, http://www.androgenstudygroup.org.
  19. A. Morgentaler, “Will I have a heart attack or stroke if I take testosterone therapy?” The Journal of Sexual Medicine, vol. 11, no. 6, pp. 1601–1602, 2014. View at Publisher · View at Google Scholar
  20. A. Morgentaler, “Testosterone, cardiovascular risk, and hormonophobia,” The Journal of Sexual Medicine, vol. 11, no. 6, pp. 1362–1366, 2014. View at Publisher · View at Google Scholar
  21. A. Morgentaler, M. Khera, M. Maggi, and M. Zitzmann, “Commentary: who is a candidate for testosterone therapy? A synthesis of international expert opinions,” The Journal of Sexual Medicine, vol. 11, no. 7, pp. 1636–1645, 2014. View at Publisher · View at Google Scholar
  22. R. D. Fletcher, R. L. Amdur, R. Kolodner et al., “Blood pressure control among US veterans: a large multiyear analysis of blood pressure data from the veterans administration health data repository,” Circulation, vol. 125, no. 20, pp. 2462–2468, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Baillargeon, R. J. Urban, Y. F. Kuo et al., “Risk of myocardial infarction in older men receiving testosterone therapy,” Annals of Pharmacotherapy, vol. 48, no. 9, pp. 1138–1144, 2014. View at Publisher · View at Google Scholar
  24. G. Corona, A. M. Isidori, J. Buvat et al., “Testosterone supplementation and sexual function: a meta-analysis study,” The Journal of Sexual Medicine, vol. 11, no. 6, pp. 1577–1592, 2014. View at Publisher · View at Google Scholar
  25. C. C. Carson III and G. Rosano, “Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data,” The Journal of Sexual Medicine, vol. 9, no. 1, pp. 54–67, 2012. View at Publisher · View at Google Scholar
  26. D. M. Kelly and T. H. Jones, “Testosterone and cardiovascular risk in men,” Frontiers of Hormone Research, vol. 43, pp. 1–20, 2014. View at Google Scholar
  27. A. Aversa, R. Bruzziches, D. Francomano et al., “Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study,” Journal of Sexual Medicine, vol. 7, no. 10, pp. 3495–3503, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. S. Tan and J. A. Salazar, “Risks of testosterone replacement therapy in ageing men,” Expert Opinion on Drug Safety, vol. 3, no. 6, pp. 599–606, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. AA. Bavry, F. Thomas, and M. Allison, “Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative,” Circulation: Cardiovascular Quality and Outcomes, vol. 7, no. 4, pp. 603–610, 2014. View at Publisher · View at Google Scholar
  30. D. J. Moskovic, A. B. Araujo, L. I. Lipschultz, and M. Khera, “The 20-year public health impact and direct cost of testosterone deficiency in U.S. men,” The Journal of Sexual Medicine, vol. 10, no. 2, pp. 562–569, 2013. View at Publisher · View at Google Scholar
  31. F. Saad, A. Haider, G. Doros, and A. Traish, “Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss,” Obesity, vol. 21, no. 10, pp. 1975–1981, 2013. View at Publisher · View at Google Scholar · View at Scopus